Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07371091 · ClinicalTrials.gov registry record
Post-market Clinical Investigation Plan: Collagen Dura Regeneration Membrane - Repair (DMR)
A clinical trial, sponsored by Collagen Matrix.
- Not yet
- Registry status
- 110
- Enrollment target
NCT07371091: Clinical Trial study, sponsored by Collagen Matrix.
NCT07371091 is a clinical trial that has not yet begun recruiting, run by Collagen Matrix. The registered enrollment target is 110 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07371091 has not yet begun recruiting, sponsored by Collagen Matrix.
- NOT YET RECRUITING
- Registry status
- 110 participants
- Enrollment target
Study Summary
Monitoring the Use of Collagen Dura Regeneration Membrane - Repair (DMR) in the Post-market Phase.
Primary Outcome
Rate of adverse events related to the Subject Device requiring surgical intervention.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2026-07 |
| Est. Completion | 2027-12 |
What is known before NCT07371091 opens enrollment
NCT07371091 is an observational study that tracks outcomes without assigning an intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT07371091 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07371091 about?
NCT07371091 is a clinical study titled "Post-market Clinical Investigation Plan: Collagen Dura Regeneration Membrane - Repair (DMR)". Monitoring the Use of Collagen Dura Regeneration Membrane - Repair (DMR) in the Post-market Phase.
What is the current status of trial NCT07371091?
This trial is currently not yet recruiting. The enrollment target is 110 participants. The study started on 2026-07. Estimated completion is 2027-12.
Who is sponsoring clinical trial NCT07371091?
This trial is sponsored by Collagen Matrix, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia